Significant differences exist with regard to time of discontinuation between different antipsychotic agents; for initial treatment, rapid onset/poor tolerability increases discontinuation, whilst for ...
Xanomeline-trospium (KarXT) — a novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent — led to statistically significant and clinically meaningful improvements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results